ATE393781T1 - Somatostatin analoge, deren radiomarkierte derivate und deren verwendung - Google Patents
Somatostatin analoge, deren radiomarkierte derivate und deren verwendungInfo
- Publication number
- ATE393781T1 ATE393781T1 AT00992965T AT00992965T ATE393781T1 AT E393781 T1 ATE393781 T1 AT E393781T1 AT 00992965 T AT00992965 T AT 00992965T AT 00992965 T AT00992965 T AT 00992965T AT E393781 T1 ATE393781 T1 AT E393781T1
- Authority
- AT
- Austria
- Prior art keywords
- somatostatin
- compounds
- radiom
- diagnosing
- labeled derivatives
- Prior art date
Links
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical class C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 title abstract 3
- 229940075620 somatostatin analogue Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 108050001286 Somatostatin Receptor Proteins 0.000 abstract 2
- 102000011096 Somatostatin receptor Human genes 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 102000005157 Somatostatin Human genes 0.000 abstract 1
- 108010056088 Somatostatin Proteins 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 229940121896 radiopharmaceutical Drugs 0.000 abstract 1
- 239000012217 radiopharmaceutical Substances 0.000 abstract 1
- 230000002799 radiopharmaceutical effect Effects 0.000 abstract 1
- 229960000553 somatostatin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15100199P | 1999-08-27 | 1999-08-27 | |
| US09/397,792 US6358491B1 (en) | 1999-08-27 | 1999-09-16 | Somatostatin analogs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE393781T1 true ATE393781T1 (de) | 2008-05-15 |
Family
ID=26848228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00992965T ATE393781T1 (de) | 1999-08-27 | 2000-08-23 | Somatostatin analoge, deren radiomarkierte derivate und deren verwendung |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6358491B1 (de) |
| EP (1) | EP1208116B1 (de) |
| JP (1) | JP2003517037A (de) |
| AT (1) | ATE393781T1 (de) |
| AU (1) | AU782873B2 (de) |
| CA (1) | CA2383936A1 (de) |
| CO (1) | CO5460266A1 (de) |
| DE (1) | DE60038739T2 (de) |
| ES (1) | ES2305000T3 (de) |
| PE (1) | PE20010516A1 (de) |
| TW (1) | TWI243178B (de) |
| WO (1) | WO2001044177A2 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001513114A (ja) * | 1997-11-24 | 2001-08-28 | ボード オブ スーパーバイザーズ オブ ルイジアナ ステイト ユニバーシティー アンド アグリカルチュラル アンド メカニカル カレッジ | 放射性同位元素標識した化合物の組織への蓄積を促進するための方法 |
| EP1283216A1 (de) * | 2001-08-10 | 2003-02-12 | Mallinckrodt Inc. | Alle somatostatinrezeptorsubtypen-bindende Somatostatinanaloge und deren Verwendung |
| DE10215336A1 (de) | 2002-03-28 | 2003-10-23 | Schering Ag | N-Methyl-Homocysteine und ihre Verwendung sowie Verfahren zu ihrer Herstellung |
| WO2003057214A1 (en) * | 2001-12-28 | 2003-07-17 | Somatocor Pharmaceuticals, Inc. | Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands |
| BRPI0414512B8 (pt) * | 2003-09-17 | 2021-05-25 | Board Of Regentes The Univ Of Texas System | composição para reproduzir imagens de um pâncreas e uso desta |
| EP1700608A1 (de) | 2005-03-10 | 2006-09-13 | Schering AG | Chelate für radioaktiv markierte Konjugate mit einer stabilisierenden Seitenkette |
| JP2008538204A (ja) * | 2005-03-10 | 2008-10-16 | バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト | 安定化側鎖を含む放射性標識複合体キレート剤 |
| EP1717247A1 (de) * | 2005-04-28 | 2006-11-02 | Schering AG | Zyklische Peptide, die sich am Somatostatinrezeptor binden |
| EP1717219A1 (de) * | 2005-04-28 | 2006-11-02 | Schering AG | Orthogonal geschützte bifunktionelle Aminosäure |
| WO2006114324A1 (en) * | 2005-04-28 | 2006-11-02 | Schering Ag | Compounds comprising cyclized somatostatin receptor binding peptides |
| US20070025910A1 (en) * | 2005-07-29 | 2007-02-01 | Norenberg Jeffrey P | Anticancer therapy |
| ES2351569B8 (es) * | 2009-05-07 | 2012-06-20 | Bcn Peptides S.A. | Ligandos peptídicos de receptores de somatostatina. |
| RU2528414C1 (ru) * | 2013-01-25 | 2014-09-20 | Закрытое Акционерное Общество "Фарм-Синтез" | Циклический октапептид, радиофармацевтическое средство на его основе и способ применения радиофармацевтического средства для получения лекарственных (фармацевтических) средств для лечения новообразований, экспрессирующих соматостатиновые рецепторы |
| WO2014139008A1 (en) * | 2013-03-15 | 2014-09-18 | Adaerata, Limited Partnership | Small molecule modulators of pcsk9 and methods of use thereof |
| CN110478495A (zh) | 2014-06-30 | 2019-11-22 | 塔弗达治疗有限公司 | 靶向缀合物及其颗粒和制剂 |
| CN108473538B (zh) | 2015-10-28 | 2022-01-28 | 塔弗达治疗有限公司 | Sstr靶向缀合物及其颗粒和制剂 |
| CA3050094C (en) | 2017-01-12 | 2024-01-02 | Radiomedix Inc. | Treatment of cancer cells overexpressing somatostatin receptors using ocreotide derivatives chelated to radioisotopes |
| CN117645652A (zh) * | 2022-09-02 | 2024-03-05 | 核欣(苏州)医药科技有限公司 | 环肽及其制备方法、包括其的复合物、及其用途 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4310518A (en) | 1979-10-31 | 1982-01-12 | Merck & Co., Inc. | Cyclic hexapeptide somatostatin analogs |
| US4486415A (en) | 1983-08-15 | 1984-12-04 | Merck & Co., Inc. | Cyclic hexapeptide somatostatin analogs |
| US4522813A (en) | 1983-10-27 | 1985-06-11 | Merck & Co., Inc. | Cyclic hexapeptide somatostatin analogs |
| EP0222578A3 (de) | 1985-11-06 | 1990-04-04 | Merck & Co. Inc. | Verwendung von cyclischen Somatostatinanaloga zur Behandlung von sofortigen Überempfindlichkeitskrankheiten |
| US5776894A (en) | 1988-12-05 | 1998-07-07 | Novartis Ag | Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors |
| US5985240A (en) | 1989-08-09 | 1999-11-16 | Rhomed Incorporated | Peptide radiopharmaceutical applications |
| US7238340B1 (en) * | 1991-11-27 | 2007-07-03 | Cis Bio International | Monoamine, diamide, thiol-containing metal chelating agents |
| US5849261A (en) * | 1991-02-08 | 1998-12-15 | Diatide, Inc. | Radiolabeled vasoactive intestinal peptides for diagnosis and therapy |
| US5783170A (en) * | 1991-11-27 | 1998-07-21 | Diatide, Inc. | Peptide-metal chelate conjugates |
| US5716596A (en) * | 1992-06-23 | 1998-02-10 | Diatide, Inc. | Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses |
| DE69426673T2 (de) * | 1993-06-23 | 2001-09-20 | Diatide, Inc. | Radiomarkierte somatostatin derivate zur abbildung und zur therapeutischen verwendung |
| US5932189A (en) * | 1994-07-29 | 1999-08-03 | Diatech, Inc. | Cyclic peptide somatostatin analogs |
| GB9417873D0 (en) | 1994-09-06 | 1994-10-26 | Sandoz Ltd | Organic compounds |
| US5597894A (en) | 1995-06-05 | 1997-01-28 | The Louisiana State University Medical Center Foundation | Multi-tyrosinated somatostatin analogs |
| US5770687A (en) | 1995-06-07 | 1998-06-23 | Peptor Limited | Comformationally constrained backbone cyclized somatostatin analogs |
| US5830431A (en) | 1995-06-07 | 1998-11-03 | Mallinckrodt Medical, Inc. | Radiolabeled peptide compositions for site-specific targeting |
| MY147327A (en) | 1995-06-29 | 2012-11-30 | Novartis Ag | Somatostatin peptides |
| US5708135A (en) | 1995-09-29 | 1998-01-13 | Biomeasure Incorporated | Cyclic peptide analogs of somatostatin |
| AT405906B (de) | 1997-03-14 | 1999-12-27 | Irene Dr Virgolini | Radiomarkierte somatostatin rezeptor-liganden zur diagnose und therapie |
-
1999
- 1999-09-16 US US09/397,792 patent/US6358491B1/en not_active Expired - Lifetime
-
2000
- 2000-08-18 TW TW089116770A patent/TWI243178B/zh not_active IP Right Cessation
- 2000-08-22 PE PE2000000852A patent/PE20010516A1/es not_active Application Discontinuation
- 2000-08-23 JP JP2001545265A patent/JP2003517037A/ja active Pending
- 2000-08-23 DE DE60038739T patent/DE60038739T2/de not_active Expired - Lifetime
- 2000-08-23 EP EP00992965A patent/EP1208116B1/de not_active Expired - Lifetime
- 2000-08-23 WO PCT/IB2000/002072 patent/WO2001044177A2/en not_active Ceased
- 2000-08-23 CA CA002383936A patent/CA2383936A1/en not_active Abandoned
- 2000-08-23 AU AU48659/01A patent/AU782873B2/en not_active Ceased
- 2000-08-23 AT AT00992965T patent/ATE393781T1/de not_active IP Right Cessation
- 2000-08-23 ES ES00992965T patent/ES2305000T3/es not_active Expired - Lifetime
- 2000-08-24 CO CO00063458A patent/CO5460266A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1208116A2 (de) | 2002-05-29 |
| EP1208116B1 (de) | 2008-04-30 |
| PE20010516A1 (es) | 2001-04-29 |
| JP2003517037A (ja) | 2003-05-20 |
| AU4865901A (en) | 2001-06-25 |
| WO2001044177A2 (en) | 2001-06-21 |
| CO5460266A1 (es) | 2004-11-30 |
| DE60038739T2 (de) | 2009-05-20 |
| CA2383936A1 (en) | 2001-06-21 |
| WO2001044177A3 (en) | 2002-03-28 |
| DE60038739D1 (de) | 2008-06-12 |
| ES2305000T3 (es) | 2008-11-01 |
| TWI243178B (en) | 2005-11-11 |
| US6358491B1 (en) | 2002-03-19 |
| AU782873B2 (en) | 2005-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60038739D1 (de) | Somatostatin analoge, deren radiomarkierte derivate und deren verwendung | |
| IL140622A0 (en) | Biphenyl sufonamide derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof | |
| DE602004012858D1 (de) | 2-aminobenzothiazole als cb1 rezeptor inverse agonisten | |
| NO20022655D0 (no) | <Beta>-2-adrenerge reseptoragonister | |
| ATE480252T1 (de) | Peptidantagonist von zonulin und dessen verwendung | |
| DK1054887T3 (da) | Bicykliske pyridin- og pyrimidinderivater som neuropeptid Y-receptorantagonister | |
| BR0208179A (pt) | Composto, composição farmacêutica, métodos para tratar distúrbios associados com o receptor 5-ht6, distúrbios cognitivos, distúrbios da mémoria, psicose, esquizofrenia, e ansiedade, e, uso de um composto | |
| AUPO755097A0 (en) | Receptor agonist and antagonist | |
| EA200400816A1 (ru) | Замещенные аналоги хиназолин-4-иламина в качестве модуляторов капсаицина | |
| DE69728585D1 (de) | Mittel gegen Juckreiz | |
| TR200100267T2 (tr) | İkameli anilid bileşimleri ve yöntemler. | |
| EP1383919A4 (de) | Verfahren und zusammensetzungen zur verwendung von mhc-klasse ii-invariante-kette-polypeptid als rezeptor für makrophagenwanderung-hemmfaktor | |
| CY1105879T1 (el) | Αζαδικυκλο παραγωγα ως ανταγωνιστες μουσκαρινικου υποδοχεα | |
| ATE481103T1 (de) | Derivate von 2-(8,9-dioxo-2,6- diazabicyclo(5.2.0)non-1(7)-en-2- yl)alkylphosphonsäure und deren verwendung als n- methyl-d-aspartat- (nmda-) rezeptorantagonisten | |
| ZA200508390B (en) | Compositions and methods for the therapy of inflammatory bowel disease | |
| ATE356623T1 (de) | 5-ht3-rezeptorantagonisten und verwendungsverfahren | |
| BR9508467A (pt) | Composição de matéria peptídeo de ligação de receptor de somatostatina composição farmacéutica e processo para realizar uma cirurgia guiada por radiosótopos ou um procedimento de radiodiagnóstico ou radioterapéutico e para aliviar uma doença relacionada com somatostetina em um animal | |
| ATE429421T1 (de) | Arylindenopyridin- und arylindenopyrimidinverbindungen und ihre verwendung als adenosin-a2a-rezeptor antagonisten | |
| EA200000198A1 (ru) | 2-ациламинопропанамины в качестве антагонистов рецепторов тахикининов | |
| NO20002408D0 (no) | 5-HT1F antagonister | |
| WO2004029218A3 (en) | Receptors and membrane-associated proteins | |
| SE0303418D0 (sv) | New use 1 | |
| SE0303419D0 (sv) | New use 11 | |
| WO2003104395A3 (en) | Receptors and membrane-associated proteins | |
| SE0303488D0 (sv) | New use 1X |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |